Understand your health. Know what to ask.
A semaglutide plateau: what to review before switching
A pause in weight change is a reason to review the treatment, not an automatic reason to switch to tirzepatide.
3 sources · NIHRead · 2 min →
How to bring wearable and lab results to a health review
How to turn wearable trends, home tests and lab reports into a useful provider conversation without treating every number as a diagnosis.
2 sources · FDARead · 2 min →
Weight changes and fatigue: looking at both together
Weight and energy can change for several reasons. A useful evaluation considers sleep, symptoms, medicines, and selected tests together.
3 sources · NIHRead · 2 min →
Your first GLP-1 consultation: what gets reviewed
A first GLP-1 visit covers health history, treatment goals, medication safety, product details and follow-up. A prescription is only one possible outcome.
4 sources · FDA, NIHRead · 2 min →
Jet lag: when the sleep schedule explains the fatigue
Crossing time zones can disrupt sleep and alertness. Learn what a travel timeline explains and when persistent fatigue needs another look.
4 sources · NIHRead · 2 min →
How to evaluate a longevity test panel
A longevity panel may mix familiar tests with experimental scores. Separate what is measured from what the result can help you decide.
4 sources · FDA, NIHRead · 2 min →
Postpartum hair shedding: when it starts and how recovery looks
Why hair sheds after pregnancy, when fullness usually returns and which changes deserve a closer look.
Read · 2 min →
GLP-1 maintenance and “microdosing”: what the labels establish
Maintaining weight loss is a treatment goal. “Microdosing” does not identify an FDA-approved regimen or guarantee fewer side effects.
4 sources · FDA, NIHRead · 2 min →
Your first blood panel: what the main numbers mean
Blood counts, metabolic tests and cholesterol measure different things. A flagged result needs the laboratory range and your health history for context.
Read · 2 min →
Night-shift fatigue: what a circadian assessment looks at
A circadian evaluation considers sleep timing, symptoms, environment and other sleep disorders. Hormone measurements are only one possible part.
3 sources · NIHRead · 2 min →
Hair thinning during perimenopause: what else can explain it?
Hair thinning in midlife may have more than one cause. How scalp findings, iron status, thyroid symptoms and timing guide the assessment.
5 sources · NIHRead · 2 min →
Semaglutide vs. tirzepatide: what single and dual action mean
Semaglutide targets GLP-1 receptors; tirzepatide targets GIP and GLP-1 receptors. How that difference fits into a treatment comparison.
3 sources · FDA, NIHRead · 2 min →